Recalls / Brands / Combipatch (estradiol/norethindrone Acetate Transdermal System)
Combipatch (estradiol/norethindrone Acetate Transdermal System)
2 FDA drug recalls involving brand “Combipatch (estradiol/norethindrone Acetate Transdermal System)”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-07-30 | Class II | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx | Noven Pharmaceuticals Inc |
| 2021-07-30 | Class II | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx On | Noven Pharmaceuticals Inc |